We have previously demonstrated that Brca1 mutation-associated breast cancers originate from luminal ER− progenitors (Molyneux et al., 2010) and that c-KIT and LYN are expressed in mouse Brca1 mammary tumors (Regan et al., 2012). This evidence concerns the gene LYN and breast carcinoma.